Thoracic SMARCA4-Deficient Undifferentiated Tumor With ALK Fusion Treated With Alectinib Achieved Remarkable Tumor Regression: Case Report

Recently, SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) has emerged as a distinct subset of lung cancer. Previous studies have suggested that SMARCA4-UT is often associated with smoking-related mutations, such as KRAS and STK11, rather than EGFR or ALK alterations. Nevertheless, no specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Jin, Han, Weidong, Pan, Hongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034452/
https://www.ncbi.nlm.nih.gov/pubmed/36969551
http://dx.doi.org/10.1016/j.jtocrr.2023.100476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034452/
https://www.ncbi.nlm.nih.gov/pubmed/36969551
http://dx.doi.org/10.1016/j.jtocrr.2023.100476

Ejemplares similares